SARS-COV2
Clinical trials for SARS-COV2 explained in plain language.
Never miss a new study
Get alerted when new SARS-COV2 trials appear
Sign up with your email to follow new studies for SARS-COV2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a pill replace the COVID-19 shot? large trial underway
⭐️ VACCINE ⭐️ OngoingThis study compares an experimental oral COVID-19 vaccine tablet to a standard mRNA booster shot. About 10,400 adults who have already received at least two mRNA vaccine doses will take part. The goal is to see if the tablet can prevent symptomatic COVID-19 as well as or better t…
Matched conditions: SARS-COV2
Phase: PHASE2 • Sponsor: Vaxart • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 15, 2026 19:06 UTC
-
Could a single X-Ray beat COVID-19 pneumonia?
Disease control OngoingThis study tests whether a single, low-dose radiation treatment to the lungs can reduce inflammation in hospitalized adults with COVID-19 pneumonia. The goal is to see if this approach lowers the need for breathing machines and shortens hospital stays. About 37 participants will …
Matched conditions: SARS-COV2
Phase: PHASE2 • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
Can a rheumatoid arthritis drug save severe COVID-19 patients?
Disease control OngoingThis study tests whether tocilizumab, a drug used for arthritis, can help people with severe or critical COVID-19 who have lung failure. About 200 adults will receive one or two doses and be followed for 30 days. The goal is to see if the drug improves survival and reduces lung d…
Matched conditions: SARS-COV2
Phase: PHASE2 • Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
Study to monitor COVID in hospital staff pulled before start
Knowledge-focused TerminatedThis study was designed to track how many healthcare workers at Lille University Hospital caught COVID-19 over 10 weeks. Researchers planned to test 100 workers every two weeks using nasal swabs and blood tests, and ask about their work and home exposures. The goal was to use the…
Matched conditions: SARS-COV2
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:05 UTC
-
French ICU study reveals key traits of severe COVID-19 patients
Knowledge-focused OngoingThis study collected information from 81 critically ill COVID-19 patients admitted to a French intensive care unit (ICU). The goal was to describe their health history, treatments, and survival rates. Researchers compared patients who were very sick with those who were less sick …
Matched conditions: SARS-COV2
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:04 UTC